Preoperative anemia is common among patients undergoing major abdominal surgery, sometimes going undetected, with a reported incidence of 30% to 70%. It increases the likelihood of blood transfusions, postoperative complications, protracted recovery, and extended hospitalizations, among other perioperative issues [1]. Although it can be life-saving, allogeneic blood transfusions may result in transfusion reactions, immunosuppression, transmission of infections, and increased healthcare costs. Consequently, patient blood management (PBM) initiatives designed to minimize unnecessary transfusions have gained significance [2, 3].
Optimizing hemoglobin levels before to surgery is crucial within the framework of PBM. Enhancing oxygen-carrying capacity, augmenting physiological reserve, and reducing the probability of intraoperative transfusion can be accomplished through the prompt detection and management of anemia. Common causes of preoperative anemia include deficiencies in iron, chronic sickness, folate, and vitamin B12, along with renal failure. If initiated well before surgery, targeted medicines that tackle these underlying issues can significantly improve hemoglobin levels. These therapies may encompass erythropoiesis-stimulating agents, nutritional support, oral or intravenous iron supplementation, among others [4, 5].
There is still a lack of uniformity in how healthcare facilities handle preoperative anemia treatment, even though there is strong evidence to support it. Time constraints before surgery, inadequate communication and collaboration among the surgical, anesthetic, and hematological teams, and an absence of established protocols are significant impediments. In light of these challenges, guidelines have been proposed for comprehensive strategies in preoperative care that encompass the screening, diagnosis, and treatment of anemia [6, 7].

This study will evaluate the efficacy of a hospital-wide preoperative hemoglobin optimization protocol to reduce the necessity for blood transfusions after major abdominal procedures. This study aims to demonstrate that an organized approach to anemia therapy enhances surgical outcomes by systematically identifying anemic patients and promptly administering evidence-based interventions.

A prospective interventional study was performed in a Department of General Medicine, S. S Institute of Medical Sciences & Research Centre, NH-4, Bypass Road, Davangere, 577005, India between September 2019 to August 2020 to assess the effect of a preoperative hemoglobin optimization protocol on intraoperative transfusion needs in patients undergoing major abdominal procedures. Forty patients planned for elective procedures, including colorectal resections, gastrectomy, hepatobiliary surgeries, and pancreatic surgeries, were enrolled during the study period. Ethical permission was secured from the Institutional Ethics Committee, and informed consent was acquired from all participants. All patients had a preoperative assessment that included a complete blood count, serum ferritin, and measurements of vitamin B12 and folate levels. Patients diagnosed with anemia were admitted to the hemoglobin optimization protocol. Inclusion Criteria: • Patients aged 18–70 years • Patients scheduled for elective major abdominal surgery • Patients with preoperative hemoglobin levels <13 g/dL (males) and <12 g/dL • Patients willing to provide informed consent Exclusion Criteria: • Emergency surgical cases • Patients with active bleeding disorders • Patients with chronic kidney disease on dialysis • Patients with malignancy receiving ongoing chemotherapy • Patients with known hypersensitivity to iron • Pregnant or lactating women Statistical Analysis: Statistical software was used to analyze the data. Hemoglobin levels and other continuous data were shown as mean ± standard deviation (SD), whilst percentages were used to represent categorical variables. The levels of hemoglobin before and after optimization were compared using the paired Student's t-test. Using the chi-square test, we examined the correlation between hemoglobin levels before surgery and the need for transfusions. It was deemed statistically significant if the p-value was less than 0.05.

The study comprised 40 individuals who were going to have major abdominal surgery. Using patient demographics, hemoglobin improvement, and intraoperative transfusion requirements as metrics, the preoperative hemoglobin optimization pathway was evaluated for its accomplishments.

Table 1: Demographic and Clinical Characteristics of Patients

At the outset, the research population's demographic and clinical details are laid out in Table 1. Males made up 60% of the patient population, and their average age was 52.4 years. The majority of surgical procedures (35% of total) were colorectal surgery. Anemia is quite common in surgical populations; in fact, 65% of patients were determined to be anemic before surgery.

Table 2: Pre- and Post-Optimization Hemoglobin Levels

The optimization technique resulted in a statistically significant improvement in hemoglobin levels, as shown in Table 2. The success of targeted therapies such iron supplements and erythropoietin therapy was indicated by the mean hemoglobin increasing from 9.8 g/dL at baseline to 11.6 g/dL before surgery (p < 0.001).

Table 3: Distribution of Hemoglobin Levels before Surgery

Based on preoperative hemoglobin levels after optimization, Table 3 demonstrates the distribution of patients. Hemoglobin levels of 11 g/dL or more were attained by 60% of patients, indicating that a considerable number of individuals in the study were able to successfully overcome anemia.

Table 4: Intraoperative Transfusion Requirements

Table 4 shows the results of the intraoperative transfusion. Compared to the previous rate of about 40%, the current rate of only 20% of patients requiring transfusion is significantly lower. The results show that optimizing hemoglobin levels before surgery significantly decreased the requirement for transfusions.

Table 5: Association between Preoperative Hemoglobin and Transfusion Rate

There is a strong correlation between hemoglobin levels before surgery and the need for transfusions, as seen in Table 5. The transfusion rate was significantly lower (8.3% vs. 37.5% for patients with hemoglobin levels below 11 g/dL) (p < 0.05). This research highlights the significance of ensuring sufficient hemoglobin levels before surgery in order to reduce the likelihood of transfusions.

This study shows that patients having major abdominal surgeries benefit greatly from enhanced hemoglobin levels and decreased intraoperative blood transfusion needs when a hospital-wide preoperative hemoglobin optimization strategy is implemented. Consistent with earlier documented prevalence rates (30-70%) in surgical groups, 65% of patients had preoperative anemia. This heavy load highlights the importance of regular screenings and prompt treatment of anemia before elective surgeries [8-10].
An important discovery in this research was the notable rise in hemoglobin levels after specific treatments, with an average increase of 9.8 ± 1.2 g/dL to 11.6 ± 1.1 g/dL (p < 0.001). Iron supplementation (both orally and intravenously), vitamin B12, folic acid, and erythropoietin therapy are all part of the personalized treatment plans that have led to these positive outcomes. Consistent with other research, our results demonstrate that addressing iron deficiency anemia before to surgery significantly improves hemoglobin levels and decreases perioperative risks [11-13].

Significantly, compared to an anticipated historical rate of about 40%, the study found that the number of patients requiring a transfusion during surgery decreased significantly to 20%. Preoperative optimization, an essential part of patient blood management (PBM), is clinically successful, as this reduction demonstrates. The risks of immunological reactions, infection transmission, and longer hospital stays are real concerns with blood transfusions, despite their frequent necessity. So, it's of great clinical importance to reduce transfusions by using preventative measures [14-16].
This study also clearly demonstrated a correlation between hemoglobin levels before surgery and the need for a transfusion. The rate of transfusion was 8.3% lower for patients with hemoglobin levels of 11 g/dL or higher compared to 37.5% for patients with hemoglobin levels below 11 g/dL. This discovery provides more evidence that even small increases in hemoglobin can reduce the risk of transfusions in a clinically significant way. Additionally, it lends credence to the idea that meeting a minimal hemoglobin threshold before surgery ought to be a crucial objective in perioperative care [17-19].
Examining the potential for a hospital-wide approach to be implemented is another crucial component of this study. By following a predetermined procedure, the surgical, anesthetic, and medical teams were better able to detect, investigate, and treat anemia as soon as it occurred. The optimization procedures adopted were safe and well-tolerated, since no side effects linked to anemia treatment were identified [20-23].
Nonetheless, we can't ignore these constraints. Because of the study's single-center design and limited sample size (n = 40), its results may not be applicable outside of that specific setting. Furthermore, it is not possible to directly compare this to standard care because there is no randomized control group [24 25]. These results should be confirmed and optimization techniques should be further refined in future research with bigger samples, multicenter designs, and evaluations of long-term outcomes [26-28].

Patients undergoing major abdominal surgery can benefit from better perioperative results when their hospital follows a defined preoperative hemoglobin optimization approach, according to the current study's authors. A considerable improvement in hemoglobin levels before surgery and a marked decrease in the need for intraoperative blood transfusions were the outcomes of early detection and focused treatment of anemia. The therapeutic value of correcting anemia as part of standard preoperative care was highlighted by the significantly reduced need for transfusion in patients who attained sufficient hemoglobin levels before surgery. The results provide credence to the idea that patient blood management measures can lessen the strain on healthcare systems, improve surgical safety, and reduce dangers associated with transfusions. This study gives good evidence that optimizing hemoglobin levels before surgery is possible and advantageous, despite its limitations (small sample size, single-center design, etc.). Greater efficiency in the use of blood resources and better patient outcomes can result from healthcare organizations adopting these standardized standards. Further validation of these findings and support for widespread clinical adoption should be provided by future large-scale investigations. Funding None Conflict of Interest: None

1. Muñoz M, Acheson AG, Auerbach M, et al. International consensus statement on the perioperative management of anaemia and iron deficiency. Anaesthesia. 2017;72(2):233–247.
2. Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet. 2013;381(9880):1855–1865.
3. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients. Transfusion. 2010;50(4):753–765.
4. Goodnough LT, Shander A. Patient blood management. Anesthesiology. 2012;116(6):1367–1376.
5. Isbister JP. Why should health professionals be concerned about blood management? Med J Aust. 2005;183(6):286–287.
6. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients. N Engl J Med. 2011;365(26):2453–2462.
7. Hébert PC, Wells G, Blajchman MA, et al. Transfusion requirements in critical care. N Engl J Med. 1999;340(6):409–417.
8. Dunne JR, Malone D, Tracy JK, et al. Perioperative anemia: an independent risk factor. J Am Coll Surg. 2002;194(5):586–593.
9. Musallam KM, Tamim HM, Richards T, et al. Preoperative anemia and postoperative outcomes. Lancet. 2011;378(9800):1396–1407.
10. Beattie WS, Karkouti K, Wijeysundera DN, et al. Risk associated with preoperative anemia. Anesthesiology. 2009;110(3):574–581.
11. Fowler AJ, Ahmad T, Phull MK, et al. Meta-analysis of preoperative anemia. Br J Surg. 2015;102(11):1314–1324.
12. Keeler BD, Simpson JA, Ng O, et al. Randomized clinical trial of preoperative oral vs intravenous iron. Br J Surg. 2017;104(3):214–221.
13. Beris P, Muñoz M, Garcia-Erce JA, et al. Perioperative anemia management. Transfus Med Rev. 2008;22(3):194–204.
14. Shander A, Javidroozi M, Ozawa S, et al. What is really dangerous: anaemia or transfusion? Br J Anaesth. 2011;107(Suppl 1):i41–i59.
15. Klein AA, Arnold P, Bingham RM, et al. AAGBI guidelines for blood transfusion. Anaesthesia. 2016;71(5):583–585.
16. Muñoz M, García-Erce JA, Cuenca J, et al. Role of parenteral iron in anemia management. Transfus Altern Transfus Med. 2009;10(1):8–22.
17. Goodnough LT, Maniatis A, Earnshaw P, et al. Detection and management of preoperative anemia. Anesth Analg. 2011;113(2):482–495.
18. Kotze A, Carter LA, Scally AJ. Effect of preoperative iron therapy. Transfus Med. 2012;22(6):362–372.
19. Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341(26):1986–1995.
20. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–1023.
21. Napolitano LM. Perioperative anemia. Surg Clin North Am. 2005;85(6):1215–1227.
22. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions. Anesthesiology. 2005;103(2):421–429.
23. Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of epoetin alfa. JAMA. 2007;288(22):2827–2835.
24. Auerbach M, Ballard H. Clinical use of intravenous iron. Hematology Am Soc Hematol Educ Program. 2010;2010:338–347.
25. Munoz M, Gomez-Ramirez S, Campos A, et al. Preoperative anemia management in surgery. Blood Transfus. 2015;13(3):370–379.
26. Ferraris VA, Davenport DL, Saha SP, et al. Surgical outcomes and transfusion. Ann Surg. 2012;256(6):902–910.
27. Hébert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe? Crit Care Med. 2001;29(2):227–234.
28. Muñoz M, Gómez-Ramírez S, Cuenca J, et al. Very-short-term perioperative iron therapy. Transfusion. 2014;54(2):289–299.